Hardie Robert D. 13D and 13G filings for Alaunos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 12:56 pm Sale | 2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | Hardie Robert D. | 68,446 4.800% | -1,682 (-2.40%) | Filing |
| 2021-02-16 1:10 pm Purchase | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | Hardie Robert D. | 70,128 4.900% | 1,254 (+1.82%) | Filing |
| 2020-02-24 12:38 pm Purchase | 2019-08-09 | 13G | Alaunos Therapeutics, Inc. TCRT | Hardie Robert D. | 68,874 5.700% | 68,874 (New Position) | Filing |